Purchase Order 75N92E24P00260
Award Date
8/14/24
Potential Completion Date
10/31/24
Potential Value
$14K
Federal Agency
National Human Genome Research Institute
Awardee
Twist Bioscience Corporation
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order valued at $22,400.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation for DNA synthesis services to support gene cloning. The contract has no set-aside designation and the ultimate completion date is December 31, 2024. Twist Bioscience is a synthetic biology company that specializes in manufacturing high-quality synthetic DNA and has...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $97,588 contract is for the provision of COVID-19 DNA constructs, which likely support genomics research, disease surveillance, and public health initiatives. This contract does not have a set-aside designation. Twist...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed price purchase order valued at $15,117.00 to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for the delivery of a TWIST Library Preparation Kit 1. This award does not have a set-aside designation. Twist Bioscience is a prime contractor on this purchase order, which has an ultimate completion date of October 14, 2024. The company...
Twist Bioscience Corporation has been awarded a firm fixed price purchase order contract valued at $24,285 by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide a custom single site variant library. As the prime contractor, Twist Bioscience will deliver the requested synthetic DNA products to support genomics research efforts. No set aside designation was applied to this award. Twist Bioscience is a manufacturer of synthetic DNA based in...
This federal contract award was issued by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The $125,565.50 firm fixed price purchase order is for the delivery of SARS COV2 RNA control products to support COVID-19 research and diagnostics efforts. The contract does not have a set-aside designation. Twist Bioscience provides various...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Twist Bioscience Corporation, a for-profit synthetic biology company, to provide TWIST RNA products for the FLUSC2 MULTIPLE program. The $51,160.00 contract does not have a set-aside designation and is scheduled for completion by April 30, 2024. Twist Bioscience, a manufacturer of goods, has previously received numerous federal contracts to supply synthetic...
This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract, valued at $578,224.78, is for the delivery of SC2 POSITIVE CONTROL SYNTHETIC RNA CONTROL MATERIAL. This contract is not associated with a set-aside program. Twist Bioscience has been awarded numerous federal contracts, primarily as a prime contractor, to provide synthetic DNA...
This federal contract award to Twist Bioscience Corporation, a synthetic biology company in South San Francisco, CA, is for the delivery of COVID-19 DNA constructs. The $29,671.85 firm fixed price purchase order was awarded on June 4, 2020 by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The contract does not have a set-aside designation. Through this award, as well as previous contracts and grants, Twist...
This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency under the National Institutes of Health (NIH), to Twist Bioscience Corporation. The $21,578.25 contract is for the delivery of oligonucleotide pools needed for a gene expression/MPRA (Massively Parallel Reporter Assay) research project. The contract has no set-aside designation and is scheduled for completion by September 30, 2024. Twist Bioscience is a synthetic biology company...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $157,390 firm fixed price purchase order contract to Twist Bioscience Corporation for the delivery of "LAP SUPPLIES." This contract, which has a completion date of September 14, 2025, does not include a set-aside designation. Twist Bioscience is a synthetic biology company that specializes in the manufacture of high-quality synthetic DNA products and services. Through this contract, Twist Bioscience will likely provide...